The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.

Saccone NL, Baurley JW, Bergen AW, et al.

Nicotine and Tobacco Research 2017

Leveraging genomic data in smoking cessation trials in the era of Precision Medicine: Why and how. 

Chen LS, Zawertailo L, Piasecki TM, et al.

Nicotine and Tobacco Research 2017

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. 

Schuit E, Panagiotou OA, Munafò MR, Bennett DA, Bergen AW, David SP

Cochrane Database Syst Rev 2017;9:CD011823

Smokescreen: a targeted genotyping array for addiction research

JW Bauerly, Edlund  CK, Pardamean  CI, Conti  DV, Bergen AW et al. 

BMC Genomics 2016, 17:145

Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans.

David SP, Wang A, Kapphahn K, et al.

EBioMedicine. 2016;4:153-61. 

Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries

James W. Baurley, PhD; Christopher K. Edlund, MS; Carissa I. Pardamean, MS; David V. Conti, PhD; Ruth Krasnow, MA; Harold S. Javitz, PhD; Hyman Hops, PhD; Gary E. Swan, PhD; Neal L. Benowitz, MD; Andrew W. Bergen, PhD

Nicotine Tob Res (2016) 18 (9): 1837-1844. DOI: 

Total Exposure Study Analysis consortium: a cross-sectional study of tobacco exposures

Bergen AW, Krasnow R, Javitz HS, Swan GE, Li MD, Baurley JW, Chen X, Murrelle L, Zedler B

BMC Public Health. 2015 Sep 7;15(1):866

Transdisciplinary Research in Cancer of the Lung Research Team.Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption

Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, Lerman C, Tyndale RF, Swan GE

PLoS One. 2015 Jul 1;10(7)

A scalable, knowledge-based analysis framework for genetic association studies

Baurley JW, Conti DV

BMC Bioinformatics. 2013 Oct 23:14(1):312

Nicotinic acetylcholine receptor variation and response to smoking cessation therapies

Bergen AW, Javitz HS, Krasnow R…Edlund CK…Swan GE

Pharmacogenet Genomics 2013, 23(2):94-103

Cloud Computing for Genome-Wide Association Analysis

Baurley JW, Edlund CK

Advances in Intelligent and Soft Computing 2012, 144:377-83.

Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study

Leng S, Stidley CA, Liu Y, Edlund CK…Belinsky SA

Cancer Res. 2012, 72(3):707-15

Discovery of complex pathways from observational data

Baurley JW, Conti DV, Gauderman WJ, Thomas DC

Stat Med 2010, 29(19):1998-2011

Complex system approaches to genetic analysis Bayesian approaches

Wilson MA, Baurley JW, Thomas DC, Conti DV

Adv Genet 2010, 72:47-71

Use of pathway information in molecular epidemiology

Thomas DC, Conti DV, Baurley J, Nijhout F, Reed M, Ulrich CMCancer Res. 2012, 72(3):707-15

Hum Genomics 2009, 4(1):21-42

Detecting gene-environment interactions in genome-wide association data

Engelman CD, Baurley JW, Chiu YF, Joubert BR, Lewinger JP, Maenner MJ, Murcray CE, Shi G, Gauderman WJGenomics 2009, 4(1):21-42

Approaches to complex pathways in molecular epidemiology: summary of a special conference of the American Association for Cancer Research

Thomas DC, Baurley JW, Brown EE, Figueiredo JC, Goldstein A, Hazra A, Wilson RT, Rothman N; American Association for Cancer Research

Cancer Res.2008, 68(24):10028-30

Snagger: a user-friendly program for incorporating additional information for tagSNP selection

Edlund CK, Lee WH, Li D, Van Den Berg DJ, Conti DV

BMC Bioinformatics 2008, 9:174

Hierarchical Bayes prioritization of marker associations from a genome-wide association scan for further investigation

Lewinger JP, Conti DV, Baurley JW, Triche TJ, Thomas DC

Genet Epidemiol. 2007, 31(8):871-82

Golden Gateway Partners, LLC

2800 S Rural Rd. 

Suite 104

Tempe, AZ 85282


Privacy Policy | Terms of Use |  Cookies Policy